Schroder Investment Management Group reduced its position in HCA Holdings, Inc. (NYSE:HCA) by 54.7% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 453,141 shares of the company’s stock after selling 546,119 shares during the period. Schroder Investment Management Group owned 0.13% of HCA worth $35,843,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Northwestern Mutual Wealth Management Co. raised its stake in HCA by 14.0% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,163 shares of the company’s stock valued at $101,000 after acquiring an additional 143 shares during the period. Bronfman E.L. Rothschild L.P. raised its stake in HCA by 35.1% in the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 1,232 shares of the company’s stock valued at $107,000 after acquiring an additional 320 shares during the period. Atlantic Trust LLC bought a new stake in HCA in the 2nd quarter valued at about $118,000. Acrospire Investment Management LLC raised its stake in HCA by 14.3% in the 2nd quarter. Acrospire Investment Management LLC now owns 1,600 shares of the company’s stock valued at $140,000 after acquiring an additional 200 shares during the period. Finally, BB&T Investment Services Inc. bought a new stake in HCA in the 2nd quarter valued at about $141,000. Institutional investors and hedge funds own 75.35% of the company’s stock.

In other news, SVP Victor L. Campbell sold 8,000 shares of the business’s stock in a transaction dated Wednesday, November 8th. The stock was sold at an average price of $78.00, for a total transaction of $624,000.00. Following the completion of the transaction, the senior vice president now owns 127,275 shares of the company’s stock, valued at $9,927,450. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Michael S. Cuffe sold 2,150 shares of the business’s stock in a transaction dated Tuesday, October 17th. The stock was sold at an average price of $78.00, for a total value of $167,700.00. Following the transaction, the insider now directly owns 12,476 shares of the company’s stock, valued at approximately $973,128. The disclosure for this sale can be found here. Insiders have sold 22,450 shares of company stock valued at $1,737,681 in the last three months. 2.90% of the stock is owned by insiders.

HCA Holdings, Inc. (NYSE:HCA) traded down $0.95 during mid-day trading on Friday, reaching $84.05. The company’s stock had a trading volume of 3,490,000 shares, compared to its average volume of 2,295,764. The company has a quick ratio of 1.41, a current ratio of 1.68 and a debt-to-equity ratio of -6.46. The stock has a market cap of $29,758.16, a price-to-earnings ratio of 12.75, a PEG ratio of 1.23 and a beta of 0.55. HCA Holdings, Inc. has a 1-year low of $70.00 and a 1-year high of $91.03.

HCA (NYSE:HCA) last posted its earnings results on Tuesday, October 31st. The company reported $1.21 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $1.21. The business had revenue of $10.70 billion during the quarter, compared to analyst estimates of $10.70 billion. HCA had a negative return on equity of 47.16% and a net margin of 6.13%. The company’s quarterly revenue was up 4.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.45 EPS. sell-side analysts expect that HCA Holdings, Inc. will post 6.56 EPS for the current fiscal year.

A number of brokerages recently issued reports on HCA. ValuEngine upgraded HCA from a “hold” rating to a “buy” rating in a research note on Thursday. J P Morgan Chase & Co upgraded HCA from a “neutral” rating to an “overweight” rating in a research note on Thursday. Mizuho restated a “buy” rating on shares of HCA in a research note on Friday, October 20th. Piper Jaffray Companies restated a “buy” rating and issued a $92.00 price objective on shares of HCA in a research note on Wednesday, October 4th. Finally, Argus lowered their price objective on HCA from $100.00 to $93.00 and set a “buy” rating on the stock in a research note on Monday, August 14th. Two investment analysts have rated the stock with a sell rating, six have issued a hold rating and eighteen have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $90.20.

COPYRIGHT VIOLATION WARNING: This report was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this report on another publication, it was illegally copied and reposted in violation of United States & international trademark & copyright laws. The legal version of this report can be viewed at https://www.thecerbatgem.com/2017/12/03/schroder-investment-management-group-lowers-position-in-hca-holdings-inc-hca.html.

HCA Company Profile

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Institutional Ownership by Quarter for HCA (NYSE:HCA)

Receive News & Stock Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related stocks with our FREE daily email newsletter.